De Novellis, D.;                     Fontana, R.;                     Giudice, V.;                     Serio, B.;                     Selleri, C.    
        Innovative Anti-CD38 and Anti-BCMA Targeted Therapies in Multiple Myeloma: Mechanisms of Action and Resistance. Int. J. Mol. Sci. 2023, 24, 645.
    https://doi.org/10.3390/ijms24010645
    AMA Style
    
                                De Novellis D,                                 Fontana R,                                 Giudice V,                                 Serio B,                                 Selleri C.        
                Innovative Anti-CD38 and Anti-BCMA Targeted Therapies in Multiple Myeloma: Mechanisms of Action and Resistance. International Journal of Molecular Sciences. 2023; 24(1):645.
        https://doi.org/10.3390/ijms24010645
    
    Chicago/Turabian Style
    
                                De Novellis, Danilo,                                 Raffaele Fontana,                                 Valentina Giudice,                                 Bianca Serio,                                 and Carmine Selleri.        
                2023. "Innovative Anti-CD38 and Anti-BCMA Targeted Therapies in Multiple Myeloma: Mechanisms of Action and Resistance" International Journal of Molecular Sciences 24, no. 1: 645.
        https://doi.org/10.3390/ijms24010645
    
    APA Style
    
                                De Novellis, D.,                                 Fontana, R.,                                 Giudice, V.,                                 Serio, B.,                                 & Selleri, C.        
        
        (2023). Innovative Anti-CD38 and Anti-BCMA Targeted Therapies in Multiple Myeloma: Mechanisms of Action and Resistance. International Journal of Molecular Sciences, 24(1), 645.
        https://doi.org/10.3390/ijms24010645